View in EDS HTML Full Text PDF Full Text

Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.

Saved in:
Bibliographic Details
Title: Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
Authors: Azuly, Hovav1 (AUTHOR), Shafat, Tali1,2,3 (AUTHOR), Grupel, Daniel4,5 (AUTHOR), Porges, Tzvika5,6 (AUTHOR), Abuhasira, Ran2 (AUTHOR), Belkin, Ana7,8 (AUTHOR), Deri, Ofir9 (AUTHOR), Oster, Yonatan4,5 (AUTHOR), Zahran, Shadi4,5 (AUTHOR), Horwitz, Ehud4,5 (AUTHOR), Horowitz, Netanel A.10 (AUTHOR), Khatib, Hazim10 (AUTHOR), Batista, Marjorie Vieira11 (AUTHOR), Cortez, Anita Cassoli12 (AUTHOR), Brosh-Nissimov, Tal13,14 (AUTHOR), Segman, Yafit14,15 (AUTHOR), Ishay, Linor16,17 (AUTHOR), Cohen, Regev16,17 (AUTHOR), Atamna, Alaa18 (AUTHOR), Spallone, Amy3 (AUTHOR)
Source: Infectious Diseases & Therapy. Jan2025, Vol. 14 Issue 1, p167-180. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938229
DOI:10.1007/s40121-024-01089-9